BOTOX® for the Treatment of Platysma Prominence

PHASE2CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

April 16, 2020

Study Completion Date

April 16, 2020

Conditions
Platysma Prominence
Interventions
DRUG

BOTOX® purified neurotoxin complex

BOTOX® superficial intramuscular injections.

DRUG

Placebo

Placebo injections.

Trial Locations (12)

21030

MD Laser Skin & Vein /ID# 234532, Hunt Valley

37203

The Practice of Brian S. Biesman MD PLLC /ID# 234461, Nashville

60611

DeNova Research /ID# 238165, Chicago

75231

Dallas Plastic Surgery Institute /ID# 236528, Dallas

90069

Skin Care and Laser Physicians of Beverly Hills /ID# 236518, Los Angeles

33146-1837

Skin Research Institute LLC /ID# 238126, Coral Gables

10549-3028

The Center for Dermatology Cosmetics & Laser Surgery /ID# 235624, Mount Kisco

V5Z 4E1

Humphrey Cosmetic Dermatology /ID# 236591, Vancouver

V6H 4E1

Pacific Derm /ID# 238236, Vancouver

L7N 3N2

Dermetics Cosmetic Dermatology /ID# 236899, Burlington

M5R 3N8

Sweat Clinics of Canada /ID# 236590, Toronto

L4L 8E2

Bertucci MedSpa Inc. /ID# 236523, Woodbridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT03915067 - BOTOX® for the Treatment of Platysma Prominence | Biotech Hunter | Biotech Hunter